Pei Xu

Founder at ZHONGCHAO INC.

Net worth: 34 $ as of 2026-09-29

44 year

15 connections

Consumer Services

Commercial Services

Health Technology

Profile

Pei Xu is the founder of Zhongchao, Inc., founded in 2019, serving as Chief Financial Officer, Secretary & Director.
Current jobs include Independent Director at Estrella Immunopharma, Inc., and Chief Financial Officer at Zhongchao Medical Technology (Shanghai) Corp.
since 2016.
Former job includes Financial Director at Otsuka (China) Investment Co., Ltd. from 2008 to 2013.
Education includes an undergraduate degree from Jiangxi University of Finance & Economics.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ZHONGCHAO, INC. CLASS A 0%	2026-04-02	39 ( 0% )	34 $	2026-09-29

Pei Xu active positions

Companies	Position	Start
ZHONGCHAO INC.	Founder	2019-04-15
ESTRELLA IMMUNOPHARMA, INC.	Director/Board Member	-
Zhongchao Medical Technology (Shanghai) Corp.	Director of Finance/CFO	2013-08-31

All active positions of Pei Xu

Former positions of Pei Xu

Companies	Position	End
Otsuka (China) Investment Co., Ltd.	Director of Finance/CFO	2013-07-31

See the detail of Pei Xu's experience

Education of Pei Xu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pei Xu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Otsuka (China) Investment Co., Ltd.
Jiangxi University of Finance & Economics Jiangxi University of Finance & Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Zhongchao, Inc. Zhongchao, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as holding company whose subsidiaries provides healthcare information, education and training services to healthcare professionals	Commercial Services
Zhongchao Medical Technology (Shanghai) Corp.
Estrella Immunopharma, Inc. Estrella Immunopharma, Inc. BiotechnologyHealth Technology Operates as a preclinical-stage biopharmaceutical company focusing on cancer therapeutics to address treatment of blood cancers and solid tumors	Health Technology